Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

The Characterization of Regulatory T-Cell Profiles in Alzheimer's Disease and Multiple Sclerosis.

Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, Buttari F, Fantozzi R, Thomas A, Onofrj M, Centonze D, Miscia S, Marchisio M.

Sci Rep. 2019 Jun 19;9(1):8788. doi: 10.1038/s41598-019-45433-3.

2.

Obesity worsens central inflammation and disability in multiple sclerosis.

Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Micillo T, De Rosa V, Sica F, Furlan R, Finardi A, Fantozzi R, Storto M, Bellantonio P, Pirollo P, Di Lemme S, Musella A, Mandolesi G, Centonze D, Matarese G.

Mult Scler. 2019 Jun 4:1352458519853473. doi: 10.1177/1352458519853473. [Epub ahead of print]

PMID:
31161863
3.

A cooperation project between hospital pharmacists and general practitioners about drug interactions in clinical practice.

Vinciguerra V, Fantozzi R, Cena C, Fruttero R, Rolle C.

Eur J Hosp Pharm. 2018 Nov;25(6):301-309. doi: 10.1136/ejhpharm-2017-001253. Epub 2017 Aug 1.

PMID:
31157047
4.

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

Calabrese M, Gasperini C, Tortorella C, Schiavi G, Frisullo G, Ragonese P, Fantozzi R, Prosperini L, Annovazzi P, Cordioli C, Di Filippo M, Ferraro D, Gajofatto A, Malucchi S, Lo Fermo S, De Luca G, Stromillo ML, Cocco E, Gallo A, Paolicelli D, Lanzillo R, Tomassini V, Pesci I, Rodegher ME, Solaro C; RIREMS group (Rising Italian Researchers in Multiple Sclerosis).

Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.

5.

Histamine in the kidneys: what is its role in renal pathophysiology?

Grange C, Gurrieri M, Verta R, Fantozzi R, Pini A, Rosa AC.

Br J Pharmacol. 2019 Feb 11. doi: 10.1111/bph.14619. [Epub ahead of print] Review.

PMID:
30741418
6.

Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study.

Mirabella M, Prosperini L, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Centonze D, Cortese A, De Fino C, De Giglio L, Elia G, Fantozzi R, Ferraro E, Francia A, Galgani S, Gasperini C, Haggiag S, Landi D, Marfia GA, Millefiorini E, Monteleone F, Nociti V, Salvetti M, Sgarlata E, Pozzilli C.

CNS Drugs. 2018 Oct;32(10):963-970. doi: 10.1007/s40263-018-0543-3.

PMID:
30022464
7.

Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis.

Landi D, Ragonese P, Prosperini L, Nociti V, Haggiag S, Cortese A, Fantozzi R, Pontecorvo S, Ferraro E, Buscarinu MC, Mataluni G, Monteleone F, Salvetti M, Di Battista G, Francia A, Millefiorini E, Gasperini C, Mirabella M, Salemi G, Boffa L, Pozzilli C, Centonze D, Marfia GA.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1272-1278. doi: 10.1136/jnnp-2018-318468. Epub 2018 Jul 3.

PMID:
29970387
8.

Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.

Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, Gasperini C, Marfia GA, Millefiorini E, Nociti V, Pontecorvo S, Pozzilli C, Ruggieri S, Salvetti M, Sgarlata E, Mirabella M.

Neurology. 2018 Jul 10;91(2):e153-e161. doi: 10.1212/WNL.0000000000005772. Epub 2018 Jun 6.

PMID:
29875218
9.

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, Maniscalco GT, Di Filippo M, Buscarinu MC, Pinardi F, Gallo A, Coghe G, Pesci I, Laroni A, Gajofatto A, Calabrese M, Tomassini V, Cocco E, Solaro C; R.I.Re.MS study group.

J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

PMID:
29549468
10.

Progression of tumefactive demyelinating lesion in a child demonstrated with MRI.

De Simone M, Brogna B, Spitaleri DL, Cicarelli G, Fantozzi R, Guida B.

Radiol Case Rep. 2017 Dec 8;13(1):254-260. doi: 10.1016/j.radcr.2017.10.026. eCollection 2018 Feb.

11.

Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice.

Benetti E, Mastrocola R, Chiazza F, Nigro D, D'Antona G, Bordano V, Fantozzi R, Aragno M, Collino M, Minetto MA.

PLoS One. 2018 Jan 17;13(1):e0189707. doi: 10.1371/journal.pone.0189707. eCollection 2018.

12.

PCR-based approach for qualitative molecular analysis of six neurotropic pathogens.

Ferese R, Scorzolini L, Campopiano R, Albano V, Griguoli AM, Giardina E, Scala S, Ryskalin L, D'Alessio C, Zampatti S, Fantozzi R, Storto M, Fornai F, Gambardella S.

Acta Virol. 2017;61(3):273-279. doi: 10.4149/av_2017_305.

PMID:
28854791
13.

Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.

Gigliotti CL, Ferrara B, Occhipinti S, Boggio E, Barrera G, Pizzimenti S, Giovarelli M, Fantozzi R, Chiocchetti A, Argenziano M, Clemente N, Trotta F, Marchiò C, Annaratone L, Boldorini R, Dianzani U, Cavalli R, Dianzani C.

Drug Deliv. 2017 Nov;24(1):670-680. doi: 10.1080/10717544.2017.1303856.

14.

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.

Cannito S, Morello E, Bocca C, Foglia B, Benetti E, Novo E, Chiazza F, Rogazzo M, Fantozzi R, Povero D, Sutti S, Bugianesi E, Feldstein AE, Albano E, Collino M, Parola M.

PLoS One. 2017 Mar 1;12(3):e0172575. doi: 10.1371/journal.pone.0172575. eCollection 2017.

15.

Histamine type 1-receptor activation by low dose of histamine undermines human glomerular slit diaphragm integrity.

Veglia E, Pini A, Moggio A, Grange C, Premoselli F, Miglio G, Tiligada K, Fantozzi R, Chazot PL, Rosa AC.

Pharmacol Res. 2016 Dec;114:27-38. doi: 10.1016/j.phrs.2016.10.011. Epub 2016 Oct 14.

PMID:
27751877
16.

Enhanced selective sonosensitizing efficacy of ultrasound-based anticancer treatment by targeted gold nanoparticles.

Brazzale C, Canaparo R, Racca L, Foglietta F, Durando G, Fantozzi R, Caliceti P, Salmaso S, Serpe L.

Nanomedicine (Lond). 2016 Dec;11(23):3053-3070. Epub 2016 Sep 15.

17.

Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.

Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F, Fantozzi R, Usiello A, Maccarrone M, Mercuri NB, Lutz B, Mandolesi G, Centonze D.

J Neuroinflammation. 2016 Sep 2;13(1):231. doi: 10.1186/s12974-016-0682-8.

18.

Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.

Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D.

J Neuroinflammation. 2016 Aug 26;13(1):207. doi: 10.1186/s12974-016-0686-4.

19.

Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation.

Benetti E, Mastrocola R, Vitarelli G, Cutrin JC, Nigro D, Chiazza F, Mayoux E, Collino M, Fantozzi R.

J Pharmacol Exp Ther. 2016 Oct;359(1):45-53. doi: 10.1124/jpet.116.235069. Epub 2016 Jul 20.

PMID:
27440421
20.

In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer.

Gigliotti CL, Minelli R, Cavalli R, Occhipinti S, Barrera G, Pizzimenti S, Cappellano G, Boggio E, Conti L, Fantozzi R, Giovarelli M, Trotta F, Dianzani U, Dianzani C.

J Biomed Nanotechnol. 2016 Jan;12(1):114-27.

PMID:
27301177
21.

Targeting the NLRP3 Inflammasome to Reduce Diet-Induced Metabolic Abnormalities in Mice.

Chiazza F, Couturier-Maillard A, Benetti E, Mastrocola R, Nigro D, Cutrin JC, Serpe L, Aragno M, Fantozzi R, Ryffel B, Thiemermann C, Collino M.

Mol Med. 2016 Mar;21(1):1025-1037. doi: 10.2119/molmed.2015.00104. Epub 2016 May 9.

22.

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.

Totaro R, Di Carmine C, Costantino G, Fantozzi R, Bellantonio P, Fuiani A, Mundi C, Ruggieri S, Marini C, Carolei A.

Mult Scler Int. 2015;2015:763418. doi: 10.1155/2015/763418. Epub 2015 Jul 22.

23.

Fumaric acid esters prevent the NLRP3 inflammasome-mediated and ATP-triggered pyroptosis of differentiated THP-1 cells.

Miglio G, Veglia E, Fantozzi R.

Int Immunopharmacol. 2015 Sep;28(1):215-9. doi: 10.1016/j.intimp.2015.06.011. Epub 2015 Jun 18.

24.

Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis.

Cocco M, Garella D, Di Stilo A, Borretto E, Stevanato L, Giorgis M, Marini E, Fantozzi R, Miglio G, Bertinaria M.

J Med Chem. 2014 Dec 26;57(24):10366-82. doi: 10.1021/jm501072b. Epub 2014 Dec 4.

25.

A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice.

Collino M, Benetti E, Rogazzo M, Chiazza F, Mastrocola R, Nigro D, Cutrin JC, Aragno M, Fantozzi R, Minetto MA, Thiemermann C.

Br J Pharmacol. 2014 Dec;171(24):5802-15. doi: 10.1111/bph.12888. Epub 2014 Nov 24.

26.

Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.

Totaro R, Lugaresi A, Bellantonio P, Danni M, Costantino G, Gasperini C, Florio C, Pucci E, Maddestra M, Spitaleri D, Lus G, Ardito B, Farina D, Rossi M, Di Carmine C, Altobelli E, Maccarone B, Casalena A, De Luca G, Travaglini D, Di Ioia M, Di Tommaso V, Fantozzi R, Ruggieri S, Provinciali L, De Riso S, Mundi C, Fuiani A, Galgani S, Ruggieri S, Maniscalco GT, Giuliani G, Cartechini E, Petretta V, Fratta M, Alfieri G, Gatto M, Carolei A; Natalizumab Long-Term Treatment Study group.

Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):147-54.

PMID:
25004826
27.

B7h triggering inhibits the migration of tumor cell lines.

Dianzani C, Minelli R, Gigliotti CL, Occhipinti S, Giovarelli M, Conti L, Boggio E, Shivakumar Y, Baldanzi G, Malacarne V, Orilieri E, Cappellano G, Fantozzi R, Sblattero D, Yagi J, Rojo JM, Chiocchetti A, Dianzani U.

J Immunol. 2014 May 15;192(10):4921-31. doi: 10.4049/jimmunol.1300587. Epub 2014 Apr 11.

28.

New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization and in vitro studies.

Cavalli R, Leone F, Minelli R, Fantozzi R, Dianzani C.

Curr Drug Deliv. 2014;11(2):270-8.

29.

Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury.

Collino M, Rogazzo M, Pini A, Benetti E, Rosa AC, Chiazza F, Fantozzi R, Bani D, Masini E.

J Cell Mol Med. 2013 Nov;17(11):1494-505. doi: 10.1111/jcmm.12120. Epub 2013 Sep 20.

30.

High sugar intake and development of skeletal muscle insulin resistance and inflammation in mice: a protective role for PPAR- δ agonism.

Benetti E, Mastrocola R, Rogazzo M, Chiazza F, Aragno M, Fantozzi R, Collino M, Minetto MA.

Mediators Inflamm. 2013;2013:509502. doi: 10.1155/2013/509502. Epub 2013 Jun 18.

31.

The role of histamine in neurogenic inflammation.

Rosa AC, Fantozzi R.

Br J Pharmacol. 2013 Sep;170(1):38-45. doi: 10.1111/bph.12266. Review.

32.

Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.

Minelli R, Occhipinti S, Gigliotti CL, Barrera G, Gasco P, Conti L, Chiocchetti A, Zara GP, Fantozzi R, Giovarelli M, Dianzani U, Dianzani C.

Br J Pharmacol. 2013 Sep;170(2):233-44. doi: 10.1111/bph.12255.

33.

Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure.

Collino M, Pini A, Mugelli N, Mastroianni R, Bani D, Fantozzi R, Papucci L, Fazi M, Masini E.

Dis Model Mech. 2013 Jul;6(4):1012-20. doi: 10.1242/dmm.011528. Epub 2013 Apr 16.

34.

Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells.

Occhipinti S, Dianzani C, Chiocchetti A, Boggio E, Clemente N, Gigliotti CL, Soluri MF, Minelli R, Fantozzi R, Yagi J, Rojo JM, Sblattero D, Giovarelli M, Dianzani U.

J Immunol. 2013 Feb 1;190(3):1125-34. doi: 10.4049/jimmunol.1201816. Epub 2012 Dec 28.

35.

Acute treatment with relaxin attenuates the injury/dysfunction induced by renal ischemia/reperfusion injury.

Collino M, Rogazzoi M, Pini A, Benetti E, Rosa AC, Fantozzi R, Bani D, Masini E.

Ital J Anat Embryol. 2013;118(1 Suppl):74-6.

PMID:
24640578
36.

Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock.

Nandra KK, Collino M, Rogazzo M, Fantozzi R, Patel NS, Thiemermann C.

Dis Model Mech. 2013 May;6(3):701-9. doi: 10.1242/dmm.011353. Epub 2012 Dec 20.

37.

Overexpression of histamine H₄ receptors in the kidney of diabetic rat.

Rosa AC, Grange C, Pini A, Katebe MA, Benetti E, Collino M, Miglio G, Bani D, Camussi G, Chazot PL, Fantozzi R.

Inflamm Res. 2013 Apr;62(4):357-65. doi: 10.1007/s00011-012-0587-7. Epub 2012 Dec 22.

38.

Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation.

Collino M, Benetti E, Rogazzo M, Mastrocola R, Yaqoob MM, Aragno M, Thiemermann C, Fantozzi R.

Biochem Pharmacol. 2013 Jan 15;85(2):257-64. doi: 10.1016/j.bcp.2012.10.014. Epub 2012 Oct 24.

39.

Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.

Minelli R, Cavalli R, Ellis L, Pettazzoni P, Trotta F, Ciamporcero E, Barrera G, Fantozzi R, Dianzani C, Pili R.

Eur J Pharm Sci. 2012 Nov 20;47(4):686-94. doi: 10.1016/j.ejps.2012.08.003. Epub 2012 Aug 15.

40.

Protective effects of peroxisome proliferator-activated receptor agonists on human podocytes: proposed mechanisms of action.

Miglio G, Rosa AC, Rattazzi L, Grange C, Camussi G, Fantozzi R.

Br J Pharmacol. 2012 Oct;167(3):641-53. doi: 10.1111/j.1476-5381.2012.02026.x.

41.

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.

Patel NS, Kerr-Peterson HL, Brines M, Collino M, Rogazzo M, Fantozzi R, Wood EG, Johnson FL, Yaqoob MM, Cerami A, Thiemermann C.

Mol Med. 2012 May 9;18:719-27. doi: 10.2119/molmed.2012.00093.

42.

The non-anticoagulant heparin-like K5 polysaccharide derivative K5-N,OSepi attenuates myocardial ischaemia/reperfusion injury.

Collino M, Pini A, Mastroianni R, Benetti E, Lanzi C, Bani D, Manoni M, Fantozzi R, Masini E.

J Cell Mol Med. 2012 Sep;16(9):2196-207. doi: 10.1111/j.1582-4934.2012.01530.x. Erratum in: J Cell Mol Med. 2013 Dec;17(12):1652. Massimo, Collino [corrected to Collino, Massimo]; Alessandro, Pini [corrected to Pini, Alessandro]; Rosanna, Mastroianni [corrected to Mastroianni, Rosanna]; Elisa, Benetti [corrected to Benetti, Elisa]; Cecilia, Lanzi [corrected to Lanzi, Cecilia]; Daniel.

43.

Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes.

Rosa AC, Rattazzi L, Miglio G, Collino M, Fantozzi R.

Inflamm Res. 2012 Apr;61(4):311-7. doi: 10.1007/s00011-011-0412-8. Epub 2012 Jan 6.

PMID:
22223068
44.

Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.

Minelli R, Serpe L, Pettazzoni P, Minero V, Barrera G, Gigliotti C, Mesturini R, Rosa AC, Gasco P, Vivenza N, Muntoni E, Fantozzi R, Dianzani U, Zara GP, Dianzani C.

Br J Pharmacol. 2012 May;166(2):587-601. doi: 10.1111/j.1476-5381.2011.01768.x.

45.

A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.

Patel NS, Nandra KK, Brines M, Collino M, Wong WF, Kapoor A, Benetti E, Goh FY, Fantozzi R, Cerami A, Thiemermann C.

Mol Med. 2011 Sep-Oct;17(9-10):883-92. doi: 10.2119/molmed.2011.00053. Epub 2011 May 13.

46.

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients.

Durastanti V, Lugaresi A, Bramanti P, Amato M, Bellantonio P, De Luca G, Picconi O, Fantozzi R, Locatelli L, Solda' A, Sessa E, Totaro R, Marino S, Zipoli V, Zorzon M, Millefiorini E.

J Transl Med. 2011 Apr 18;9:42. doi: 10.1186/1479-5876-9-42.

47.

Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.

Collino M, Benetti E, Miglio G, Castiglia S, Rosa AC, Aragno M, Thiemermann C, Fantozzi R.

Free Radic Biol Med. 2011 Jan 15;50(2):345-53. doi: 10.1016/j.freeradbiomed.2010.10.710. Epub 2010 Nov 1.

48.

The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury.

Miglio G, Rosa AC, Rattazzi L, Grange C, Collino M, Camussi G, Fantozzi R.

Br J Pharmacol. 2011 Jan;162(1):111-25. doi: 10.1111/j.1476-5381.2010.01032.x.

49.

B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells.

Dianzani C, Minelli R, Mesturini R, Chiocchetti A, Barrera G, Boscolo S, Sarasso C, Gigliotti CL, Sblattero D, Yagi J, Rojo JM, Fantozzi R, Dianzani U.

J Immunol. 2010 Oct 1;185(7):3970-9. doi: 10.4049/jimmunol.0903269. Epub 2010 Sep 3.

50.

Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.

Kapoor A, Shintani Y, Collino M, Osuchowski MF, Busch D, Patel NS, Sepodes B, Castiglia S, Fantozzi R, Bishop-Bailey D, Mota-Filipe H, Yaqoob MM, Suzuki K, Bahrami S, Desvergne B, Mitchell JA, Thiemermann C.

Am J Respir Crit Care Med. 2010 Dec 15;182(12):1506-15. doi: 10.1164/rccm.201002-0240OC. Epub 2010 Aug 6.

PMID:
20693380

Supplemental Content

Loading ...
Support Center